Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 842 | 915 | 1,543 | 4,290 | 7,453 |
| Receivables | 88 | 131 | 55 | 395 | 410 |
| Inventories | 237 | 245 | 255 | 271 | 261 |
| Other current assets | 0 | 0 | 0 | 0 | 29 |
| TOTAL | $4,548 | $3,994 | $4,159 | $8,422 | $11,777 |
| Non-Current Assets | |||||
| PPE Net | 46 | 50 | 55 | 60 | 55 |
| Other Non-Current Assets | 49 | 53 | 2 | 6 | 10 |
| TOTAL | $95 | $104 | $57 | $66 | $65 |
| Total Assets | $4,643 | $4,097 | $4,215 | $8,488 | $11,842 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,078 | 4,483 | 3,481 | 2,870 | 2,092 |
| TOTAL | $6,096 | $4,500 | $3,481 | $2,875 | $2,102 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 32 | 37 | 0 | 0 | 0 |
| TOTAL | $32 | $37 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,128 | $4,536 | $3,481 | $2,875 | $2,102 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,308 | 15,168 | 10,555 | 8,482 | 8,439 |
| Common Shares | 2 | 1 | 1 | 1 | 1 |
| Retained earnings | -73,443 | -68,807 | -63,799 | -58,819 | -54,572 |
| TOTAL | $-1,485 | $-439 | $735 | $5,613 | $9,740 |
| Total Liabilities And Equity | $4,643 | $4,097 | $4,215 | $8,488 | $11,842 |